Clinical-trial insurance brokerage
Specialist insurance brokers who structure and place subject-injury, professional-indemnity and product-liability coverage for a clinical trial program, harmonizing the statutorily-required local insurance of every country a trial runs in into a single manageable placement.
1 · What it gives
Clinical-trial insurance brokerage places the coverage a sponsor is legally required to carry — or contractually obligated to provide a site under a Clinical Trial Agreement — before a study can enroll its first subject. Newline Group, a Lloyd’s-market underwriting manager based in London, runs a dedicated Clinical Trials product line offering life-of-trial policies of up to ten years’ duration, country-specific annual “all trial” policies, and bespoke multi-country or global master difference-in-conditions/difference-in-limits programs. Marsh, one of the world’s largest insurance brokers, is named among the leading placement houses for clinical-trial coverage by independent market comparisons. Howden, a UK-headquartered global broker, published a 2026 sector report on how insurance can support the UK pharma industry through its current transition, reflecting its active life-sciences practice. Gallagher’s Life Sciences practice published a dedicated whitepaper, “Mitigating Risks Through Clinical Trial Funding Insurance,” alongside a Winter 2026 market summary specifically covering pharmaceutical, biotechnology, medical-device, CRO and CMO clients. WTW (Willis Towers Watson) publishes ongoing analysis of clinical-trial insurance underwriting trends, including the growing role of trial medical-expense coverage and 2025 rate predictions for life-sciences products and professional liability.
The key directions of clinical-trial insurance brokerage are:
- Subject-injury and liability placement: structuring coverage for bodily injury and medical expenses incurred by trial participants, alongside sponsor and site professional-indemnity and product-liability exposure.
- Multi-jurisdiction program harmonization: placing a single master or difference-in-conditions/difference-in-limits policy that satisfies the differing statutory clinical-trial insurance requirements of every country a study runs in.
- Life-of-trial and annual policy structuring: choosing between a single policy covering a trial’s full multi-year duration versus renewable annual “all trial” country-specific policies, depending on program length and portfolio size.
- Site indemnification advisory: advising sponsors and research sites on the insurance and indemnification terms of the Clinical Trial Agreement or Master Services Agreement before a site signs on.
Sectoral value chain#
[Trial protocol & jurisdiction scoping] ──> [Coverage structuring & underwriter placement] ──> [Policy issuance across trial countries]
│
(Site indemnification review)
│
[Claims handling to closure] <──── [Ongoing program renewal/amendment] <─── [Subject-injury claim intake]
Value chain levels#
| Level | Description | Key inputs/outputs |
|---|---|---|
| Protocol & jurisdiction scoping | Reviewing the trial protocol and the list of countries/sites it will run in to determine the statutory insurance requirements that apply. | In: Trial protocol, site/country list. Out: Jurisdictional coverage requirement matrix. |
| Coverage structuring & placement | Structuring the policy (life-of-trial vs. annual, master vs. local) and placing it with underwriters. | In: Jurisdictional coverage requirement matrix. Out: Placed insurance program. |
| Policy issuance across trial countries | Issuing the local policy documentation required in each jurisdiction under the master program. | In: Placed insurance program. Out: Country-specific policy documents. |
| Site indemnification review | Advising sponsor and site on the Clinical Trial Agreement’s insurance and indemnification terms before signing. | In: Country-specific policy documents, draft CTA/MSA. Out: Reviewed indemnification terms. |
| Subject-injury claim intake | Receiving and triaging a reported subject-injury or liability event during trial conduct. | In: Reported adverse/injury event. Out: Intake claim file. |
| Claims handling to closure | Managing the claim through investigation, negotiation and settlement or denial, and feeding lessons into program renewal. | In: Intake claim file. Out: Closed claim, renewal/amendment input. |
Cross-cutting technologies of the sector:
- Clinical-trial liability placement: specialist insurance-broking practice that structures and places subject-injury, professional-indemnity and product-liability coverage for a specific clinical trial program across the jurisdictions it runs in.
- Multi-country trial insurance programs: master or difference-in-conditions/difference-in-limits insurance policies that harmonize local, statutorily-required clinical-trial coverage across every country a sponsor’s trial operates in under one program.
2 · What it replaces 0 · matched by industry
No graded substitution linked yet.
3 · How to implement 6 steps
- 1Protocol and jurisdiction scopingThe broker reviews the trial protocol and the list of countries and sites it will run in to determine which statutory clinical-trial insurance requirements apply.
- 2Coverage structuring and underwriter placementThe broker structures the policy — life-of-trial or annual, master program or local — and places it with one or more underwriters, often via the Lloyd’s market for specialist life-sciences risk.
- 3Policy issuance across trial countriesLocal policy documentation required in each jurisdiction is issued under the umbrella of the master program.
- 4Site indemnification reviewThe broker or sponsor’s risk team reviews the Clinical Trial Agreement or Master Services Agreement’s insurance and indemnification terms before a site signs.
- 5Subject-injury claim intakeA reported subject-injury or liability event during trial conduct is received and triaged into a claim file.
- 6Claims handling to closureThe claim is investigated, negotiated and settled or denied, with lessons feeding back into the next program renewal or amendment.
4 · Who delivers
Matched suppliers (matched automatically)
| Tsumura | Japan | Producer | active |
| Biohaven | United States | Research / RTO | active |
| Recursion Pharmaceuticals | United States | Research / RTO | active |
| Genmab | Denmark | Producer | active |
| Nostoc Biotech | Spain | Producer | active |
| Nada - ندى | Saudi Arabia | Producer | active |
| Fresenius | Germany | Producer | active |
| Vinaseed | Vietnam | Research / RTO | active |
| Milwhite, Inc. | United States | Research / RTO | active |
Leading companies and institutes (from the brief)
| Company / Institute | Country | Key products / platforms | Tech features | Status 2026 |
|---|---|---|---|---|
| Newline Group | 🇬🇧 UK | Dedicated Clinical Trials product line (Lloyd’s) | Life-of-trial policies to 10 years, multi-country DIC/DIL | commercial |
| Marsh | 🇺🇸 USA | Clinical-trial insurance placement | Leading global placement scale | commercial |
| Howden | 🇬🇧 UK | Life-sciences insurance broking | UK pharma-sector transition advisory | commercial |
| Gallagher | 🇺🇸 USA | Life Sciences practice, clinical-trial funding insurance | Dedicated whitepaper + market-summary research | commercial |
| WTW | 🇬🇧 UK | Clinical-trial insurance underwriting analysis | Trial medical-expense coverage evolution tracking | commercial |
5 · Rules & route to market
United States
The United States hosts two of the largest global insurance-broking houses with dedicated life-sciences practices covering clinical-trial placement.
Marsh’s placement scale, Gallagher’s dedicated Life Sciences whitepaper#
- Marsh: named among the leading clinical-trial insurance placement brokers in independent market comparisons, leveraging its position as one of the world’s largest insurance brokers to place complex, cross-border trial programs.
- Gallagher: its Life Sciences practice publishes dedicated clinical-trial funding insurance guidance and a recurring life-sciences insurance market summary covering pharmaceutical, biotech, medical-device, CRO and CMO clients specifically.
European Union
The European Union — via UK-headquartered brokers and Lloyd’s-market underwriters — hosts the deepest specialist clinical-trial insurance capacity, including the sector’s dedicated Lloyd’s product line.
Newline’s dedicated Lloyd’s product line, Howden’s UK life-sciences transition report, WTW’s underwriting-trend analysis#
- Newline Group: a Lloyd’s-market underwriting manager running a dedicated Clinical Trials product line — life-of-trial policies up to ten years, country-specific annual “all trial” policies, and bespoke multi-country or global master difference-in-conditions/difference-in-limits programs.
- Howden: published a 2026 report on how insurance can support the UK pharmaceutical and life-sciences sector through its current transition, reflecting an active dedicated life-sciences broking practice.
- WTW (Willis Towers Watson): publishes ongoing analysis of clinical-trial insurance underwriting trends, including trial medical-expense coverage evolution and life-sciences product/professional-liability rate predictions.
China
China is covered qualitatively rather than by a live-screened Chinese vendor: candidate Chinese clinical-trial insurance brokers searched during this screen returned no confirming 2026 source, so no Chinese company is tabled below. Multinational sponsors running trials in China typically place local statutorily-required coverage through the same global brokers’ China offices or local co-insurance partners, rather than through a distinct domestic clinical-trial-insurance specialist confirmed on this screen.
No confirmed domestic specialist; global brokers’ China offices place local statutory coverage#
- Global broker China offices: multinational sponsors running China trial sites typically route the locally-required clinical-trial insurance placement through the same global brokers’ China operations rather than a distinct domestic specialist.
- Domestic gap: no China-headquartered clinical-trial insurance brokerage confirmed by a live 2026 source was found during this screen.
6 · Money: tenders & grants
| Grant | NIAID Clinical Trial Implementation Cooperative Agreement (U01 Clinical Trial Required) National Institutes of Health · United States | Jul 5, 2029 955 days |
| Grant | First in Human and Early Stage Clinical Trials of Novel Investigational Drugs or Neuromodulatory Device-based … National Institutes of Health · United States | Oct 15, 2027 326 days |
| Grant | Blueprint Neurotherapeutics Network (BPN): Biologic-based Drug Discovery and Development for Disorders of the … National Institutes of Health · United States | Aug 18, 2027 268 days |
| Grant | Development of Collaborative Research Facilities or Research-Resource Facilities (C06 Clinical Trial Not … National Institutes of Health · United States | Jan 25, 2028 428 days |
| Grant | Agriculture and Food Research Initiative Competitive Grants Program Foundational and Applied Science Program National Institute of Food and Agriculture · United States | Dec 31, 2026 38 days |
7 · Tech stack & innovations
The clinical-trial insurance brokerage “technology stack” is less software than structuring know-how, applied through a small set of recurring policy mechanisms:
- Difference-in-conditions/difference-in-limits (DIC/DIL) master programs:
- Newline’s global master programs harmonize varying local statutory minimums into one placement, avoiding a patchwork of separately negotiated local policies.
- Life-of-trial vs. annual policy structuring:
- Brokers choose between a single policy spanning a trial’s full multi-year duration and renewable annual all-trial policies, trading premium certainty against flexibility as a program’s country footprint changes.
- Sector-specific market-trend research feeding placement strategy:
- Gallagher and WTW both publish recurring life-sciences insurance market analysis that directly informs how a given trial program is structured and timed for placement.
Sources 5 · 0 independent · 5 producer sites
Producers' own sites 5
- Newline producer checked 2026-08-12 · link not kept
- Marsh producer checked 2026-08-11 · link not kept
- Howden producer checked 2026-08-11 · link not kept
- Gallagher producer checked 2026-07-13 · link not kept
- Wtw producer checked 2026-07-31 · link not kept